Advertisement
Research Article Free access | 10.1172/JCI118695
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Find articles by Tang, T. in: JCI | PubMed | Google Scholar
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Find articles by Frenette, P. in: JCI | PubMed | Google Scholar
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Find articles by Hynes, R. in: JCI | PubMed | Google Scholar
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Find articles by Wagner, D. in: JCI | PubMed | Google Scholar
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Find articles by Mayadas, T. in: JCI | PubMed | Google Scholar
Published June 1, 1996 - More info
Leukocyte accumulation in cerebrospinal fluid and disruption of the blood-brain barrier are central components of meningitis and are associated with a poor prognosis. Genetically engineered deficiencies or functional inhibition of endothelial leukocyte adhesion receptors P-, or P- plus E-selectins, lead to deficits in leukocyte rolling and extravasation. However, their impact on meningeal inflammation has not been tested previously. An acute cytokine-induced meningitis model associated with significant cerebrospinal fluid leukocyte accumulation (averaging 14,000 leukocytes/microl as early as 4 h) and blood-brain barrier permeability was developed in adult mice. This model was applied to mice deficient in P-selectin and mice doubly deficient in P- and E-selectins. Partial inhibition of cerebrospinal fluid leukocyte influx and permeability was noted in P-selectin-deficient mice. Mice doubly deficient in P- and E-selectins displayed a near complete inhibition of these parameters. Our results suggest that P- and E-selectins cooperatively contribute to meningitis and that functional blocking of both endothelial selectins in conjunction with antibiotics may provide a therapeutic approach for treatment of bacterial meningitis.